BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34545699)

  • 1. Does timing matter in radiotherapy of hepatocellular carcinoma? An experimental study in mice.
    Hassan SA; Ali AAH; Sohn D; Flögel U; Jänicke RU; Korf HW; von Gall C
    Cancer Med; 2021 Nov; 10(21):7712-7725. PubMed ID: 34545699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-dependent changes in proliferation, DNA damage and clock gene expression in hepatocellular carcinoma and healthy liver of a transgenic mouse model.
    Hassan SA; Schmithals C; von Harten M; Piiper A; Korf HW; von Gall C
    Int J Cancer; 2021 Jan; 148(1):226-237. PubMed ID: 32700769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
    Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
    J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sonic Hedgehog inhibition as a strategy to augment radiosensitivity of hepatocellular carcinoma.
    Tsai CL; Hsu FM; Tzen KY; Liu WL; Cheng AL; Cheng JC
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1317-24. PubMed ID: 25682950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy of the Hepatocellular Carcinoma in Mice Has a Time-Of-Day-Dependent Impact on the Mouse Hippocampus.
    Yassine M; Hassan SA; Sommer S; Yücel LA; Bellert H; Hallenberger J; Sohn D; Korf HW; von Gall C; Ali AAH
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between locomotor activity rhythm and corticosterone levels during HCC development, progression, and treatment in a mouse model.
    Hassan SA; Ali AAH; Yassine M; Sohn D; Pfeffer M; Jänicke RU; Korf HW; von Gall C
    J Pineal Res; 2021 Apr; 70(3):e12724. PubMed ID: 33615553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
    Song W; Zhang J; Xia Q; Sun M
    Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
    [No Abstract]   [Full Text] [Related]  

  • 8. Establishment of image-guided radiotherapy of orthotopic hepatocellular carcinoma mouse model.
    Zhou K; Jiang Y; Feng S; Mo W; Nie J; Cao J; Jiao Y
    Animal Model Exp Med; 2023 Oct; 6(5):419-426. PubMed ID: 37365733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma.
    Liao J; Jin H; Li S; Xu L; Peng Z; Wei G; Long J; Guo Y; Kuang M; Zhou Q; Peng S
    J Exp Clin Cancer Res; 2019 Nov; 38(1):454. PubMed ID: 31694662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy for hepatocellular carcinoma: systematic review of radiobiology and modeling projections indicate reconsideration of its use.
    Wigg AJ; Palumbo K; Wigg DR
    J Gastroenterol Hepatol; 2010 Apr; 25(4):664-71. PubMed ID: 20074152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver damage and senescence increases in patients developing hepatocellular carcinoma.
    Rey S; Quintavalle C; Burmeister K; Calabrese D; Schlageter M; Quagliata L; Cathomas G; Diebold J; Molinolo A; Heim MH; Terracciano LM; Matter MS
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1480-1486. PubMed ID: 28052383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of electroacupuncture at different time on circadian rhythm and SCN epigenetic modification in mice with hepatocellular carcinoma].
    Hou S; Zheng S; Wang J; Chen X; Zhong Z; Xue H; Chen S
    Zhongguo Zhen Jiu; 2018 Aug; 38(8):864-70. PubMed ID: 30141298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the JNK-c-Jun pathway in response to irradiation facilitates Fas ligand secretion in hepatoma cells and increases hepatocyte injury.
    Dong Y; Shen X; He M; Wu Z; Zheng Q; Wang Y; Chen Y; Wu S; Cui J; Zeng Z
    J Exp Clin Cancer Res; 2016 Jul; 35(1):114. PubMed ID: 27431384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [LncRNA HULC promots HCC growth by downregulating miR-29].
    Zhu LR; Feng JL; Liu XJ; Wang JM
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):659-666. PubMed ID: 31550855
    [No Abstract]   [Full Text] [Related]  

  • 20. lncRNA HAND2-AS1 overexpression inhibits cancer cell proliferation in hepatocellular carcinoma by downregulating RUNX2 expression.
    Jing GY; Zheng XZ; Ji XX
    J Clin Lab Anal; 2021 Apr; 35(4):e23717. PubMed ID: 33566427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.